Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke
Phase 2
Completed
- Conditions
- Ischemic Stroke
- Interventions
- Drug: placeboDrug: SA4503 LowDrug: SA4503 High
- First Posted Date
- 2008-03-20
- Last Posted Date
- 2009-07-29
- Lead Sponsor
- M's Science Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT00639249
- Locations
- 🇬🇧
Southern General Hospital, Glasgow, United Kingdom
SA4503 8-Week Study in Major Depressive Disorder (MDD)
Phase 2
Completed
- Conditions
- Depressive Disorder, Major
- Interventions
- Drug: placeboDrug: SA4503 LowDrug: SA4503 High
- First Posted Date
- 2007-10-30
- Last Posted Date
- 2008-12-18
- Lead Sponsor
- M's Science Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT00551109
© Copyright 2025. All Rights Reserved by MedPath